Chondrosphere® ACT (Prod 4247)






About Chondrosphere® ACT (Prod 4247)

Cell based biologic which was developed as a minimally invasive third generation of the autologous chondrocyte transplantation (ACT)

The ACT is strictly autologous and the cells produce their own matrix.

The chondrocyte transplantation includes removal of the cartilage tissue within an arthroscopic surgery. Chondrocytes are isolated from this tissue sample and cultivated under sterile conditions in the highly specialized cell culture laboratories of co.don® AG. In case of the classical ACT, an autologous periosteal flap is taken and sutured watertight over the defect. The cultured autologous chondrocytes are then injected into the forming hollow space.

Request Product Information

Disclaimer:

OrthopaedicLIST.com is a list of products and services. Every effort is made to keep this listing as accurate and current as possible. Companies and individuals are encouraged to notify us of errors and omissions. We will respond to such messages of correction in a timely fashion, as our workload permits.

We are non-judgmental of products listed. We are not in the business of evaluating products. We have not evaluated these products. We make no representations as to the quality, effectiveness, suitability or appropriateness of any of the products listed.

As an important component of the service function of OrthopaedicLIST.com, some products continue to be listed that are no longer manufactured and may not be available. We will identify them as such when possible. This allows users to find special instruments and/or components for removal, modification, and/or revision of those products.